Table 1

Pharmaceutical assessment screening tool (PAST) factors for all sampled patients

Pharmaceutical assessment screening factorsNumber (%)
N35
Organ dysfunction
 Kidney8 (23)
 Liver1 (3)
 Heart0 (0)
 Lung0 (0)
 Bone marrow0 (0)
 Brain0 (0)
 Dysfunction of more than one organ0 (0)
Drugs requiring therapeutic monitoring
 Glycopeptide antibiotic1 (3)
 Aminoglycosides4 (11)
 Theophylline/aminophylline3 (9)
 Digoxin1 (3)
 Carbamazepine0 (0)
 Lithium0 (0)
 Ciclosporin0 (0)
 Amphotericin B0 (0)
 Triazole antifungals0 (0)
Number of drugs requiring therapeutic monitoring
 028 (80)
 15 (14)
 22 (6)
Other high-risk medications
 Anticoagulation5 (14)
 Insulin8 (23)
 Opiates6 (17)
 Chemotherapy0 (0)
 Antiretrovirals0 (0)
 Clozapine0 (0)
Number of high-risk medications*
 018 (51)
 18 (23)
 27 (20)
 32 (6)
ICU step-down patient1 (3)
Patient with an infectious disease consult0 (0)
Patient with cystic fibrosis5 (14)
Organ transplant patient0 (0)
Home intravenous therapy0 (0)
Out-of-hospital respiratory service0 (0)
Patient with HIV0 (0)
Patient with Parkinson's disease on apomorphine0 (0)
High-cost medication (not within NHS tariff)0 (0)
Outside competency of attending pharmacist†0 (0)
Pharmacist-documented PAL
 14 (11)
 225 (71)
 36 (17)
Expected PAL
 111 (31)
 215 (43)
 39 (26)
Measured agreement of PAL‡
 −20 (0)
 −16 (17)
  020 (57)
 +18 (23)
 +21 (3)
  • *Number of high-risk medications includes drugs requiring therapeutic monitoring plus other high-risk medications.

  • †Outside competency refers to documentation by a junior pharmacist that the patient’s complexity is outside the scope of their competency.

  • ‡Measured agreement of PALs is the difference of pharmacist-documented PAL minus the expected PAL with a range of values from −2 to +2.

  • ICU, intensive care unit; NHS, National Health Service; PAL, patient acuity level.